The Pathophysiology of Cholangiocarcinoma, a Review about Possible Involved Risk Factors

Yacob Habboush and Noor Daoud Pac
Additional contact information
Yacob Habboush: Orange Park Medical Center, Jacksonville, FL, USA
Noor Daoud Pac: Baptist Health, Jacksonville, FL, USA

Novel Approaches in Drug Designing & Development, 2018, vol. 4, issue 2, 47-53

Abstract: Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy. CCA is divided into three main categories, Intrahepatic CCA (iCCA), perihilar CCA (pCCA), and distal extrahepatic CCA (eCCA). iCCA is considered to be the most aggressive among all types of CCA. Although the incidence of iCCA are on the rise worldwide, few of the risk factors related to iCCA have been elucidated and many have not been well-recognized. Therefore, an organized categorization of the risk factors is necessary to better understand the causes of iCCA. Consequently, this would help in screening those individuals that are at a higher risk for iCCA. We have proposed a categorization of risk factors based on previously published literature in the following manner: well-established risk factors, emerging risk factors, suspected risk factors, and unknown risk factors. Hence, will help medical and public health professionals in identifying determinants of health that might be highly influential and be able to prevent a disease with a poor prognosis.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555634.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555634.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:4:y:2018:i:2:p:47-53

DOI: 10.19080/NAPDD.2018.04.555634

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().